![PredictImmune Ltd on X: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for PredictImmune Ltd on X: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for](https://pbs.twimg.com/media/EZGMSJWWsAASsuT.jpg)
PredictImmune Ltd on X: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for
![Ferring Pharmaceuticals on Twitter: "We're looking forward to Ferring's exclusive live webinar on March 7th, 2022 – 'From the Podium to the Clinic: Best of ECCO 2022'. Register here: https://t.co/BljzKdw99U #Ferring #Gastroenterology # Ferring Pharmaceuticals on Twitter: "We're looking forward to Ferring's exclusive live webinar on March 7th, 2022 – 'From the Podium to the Clinic: Best of ECCO 2022'. Register here: https://t.co/BljzKdw99U #Ferring #Gastroenterology #](https://pbs.twimg.com/media/FMW1vdgWQAAnheT.jpg)
Ferring Pharmaceuticals on Twitter: "We're looking forward to Ferring's exclusive live webinar on March 7th, 2022 – 'From the Podium to the Clinic: Best of ECCO 2022'. Register here: https://t.co/BljzKdw99U #Ferring #Gastroenterology #
![ECCO 2023 Insights: Advancements in IBD Management and the Application to Rheumatology - European Medical Journal ECCO 2023 Insights: Advancements in IBD Management and the Application to Rheumatology - European Medical Journal](https://embed-ssl.wistia.com/deliveries/b07f91438f7a5acc6d5fe5046d07a807/file..jpg?image_crop_resized=1920x1080)
ECCO 2023 Insights: Advancements in IBD Management and the Application to Rheumatology - European Medical Journal
![ECCO 2022 Insights: Treatment developments for irritable bowel disease (IBD) and rheumatology - European Medical Journal ECCO 2022 Insights: Treatment developments for irritable bowel disease (IBD) and rheumatology - European Medical Journal](https://fast.wistia.net/embed/medias/kf6v06ruja/thumbnail-320.webp)